These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28384634)

  • 1. Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.
    Taniguchi T; Kishi K; Nakagawa T; Tanaka H; Tanaka T; Tomonari T; Okamoto K; Sogabe M; Miyamoto H; Okahisa T; Muguruma N; Kajimoto M; Sagawa I; Takayama T
    Digestion; 2017; 95(3):242-251. PubMed ID: 28384634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Sakamoto A
    Int J Oncol; 2008 Dec; 33(6):1149-55. PubMed ID: 19020747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Fujikawa T; Shiraha H; Yamamoto K
    Acta Med Okayama; 2009 Dec; 63(6):299-304. PubMed ID: 20035286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
    Yamagata H; Nakanishi T; Furukawa M; Okuda H; Obata H
    J Gastroenterol Hepatol; 1995; 10(1):8-13. PubMed ID: 7620113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
    Int J Oncol; 2010 Jan; 36(1):161-70. PubMed ID: 19956845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Des-gamma-carboxy prothrombin in hepatocellular cancer patients waiting for liver transplant: a systematic review and meta-analysis.
    Lai Q; Iesari S; Levi Sandri GB; Lerut J
    Int J Biol Markers; 2017 Oct; 32(4):e370-e374. PubMed ID: 28561879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
    Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
    Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
    Int J Oncol; 2009 Nov; 35(5):1005-14. PubMed ID: 19787254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
    Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.
    Matsubara M; Shiraha H; Kataoka J; Iwamuro M; Horiguchi S; Nishina S; Takaoka N; Uemura M; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yamamoto K
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1602-8. PubMed ID: 22554292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Des-gamma-carboxy prothrombin (DCP) antagonizes the effects of gefitinib on human hepatocellular carcinoma cells.
    Cui SX; Zhang YS; Chu JH; Song ZY; Qu XJ
    Cell Physiol Biochem; 2015; 35(1):201-12. PubMed ID: 25591763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
    Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
    Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Des-γ-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.
    Sumi A; Akiba J; Ogasawara S; Nakayama M; Nomura Y; Yasumoto M; Sanada S; Nakashima O; Abe T; Yano H
    PLoS One; 2015; 10(3):e0118452. PubMed ID: 25739032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study.
    Okuda H; Obata H; Nakanishi T; Furukawa R; Hashimoto E
    J Hepatol; 1987 Jun; 4(3):357-63. PubMed ID: 3036940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Des-γ-carboxy prothrombin and c-Met were concurrently and extensively expressed in hepatocellular carcinoma and associated with tumor recurrence.
    Gao J; Feng X; Inagaki Y; Song P; Kokudo N; Hasegawa K; Sugawara Y; Tang W
    Biosci Trends; 2012 Aug; 6(4):153-9. PubMed ID: 23006961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of des-gamma-carboxy prothrombin levels in hepatocellular carcinoma and liver tissues.
    Shimada M; Yamashita Y; Hamatsu T; Hasegawa H; Utsunomiya T; Aishima S; Sugimachi K
    Cancer Lett; 2000 Oct; 159(1):87-94. PubMed ID: 10974410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma.
    Suzuki H; Murata K; Gotoh T; Kusano M; Okano H; Oyamada T; Yasuda Y; Imamura M; Kudo M; Mizokami M; Sakamoto A
    J Gastroenterol; 2011 Oct; 46(10):1219-29. PubMed ID: 21744129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
    Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas.
    Huisse MG; Leclercq M; Belghiti J; Flejou JF; Suttie JW; Bezeaud A; Stafford DW; Guillin MC
    Cancer; 1994 Sep; 74(5):1533-41. PubMed ID: 7520347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.